Home › Cancer sa Matris › New York
Pag-aaral pangklinika para sa Cancer sa Matris sa New York
8 pag-aaral para sa Cancer sa Matris ang naghahanap ng mga kalahok sa mga site sa New York.
Mga Lungsod sa New York
Opisyal na teksto ng pag-aaral (English)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Maimonides Medical Center, Brooklyn
- Columbia University Medical Center - Herbert Irving Pavilion, New York
- IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT06952660DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, New York
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT06989112PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Northwell Health Cancer Institute at Huntington, Greenlawn
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT04329494Investigations of Reproductive Cancers in Women
- Columbia University, New York
Nagre-recruitObservasyonal na pag-aaral
Edad 45 hanggang 100 · Kababaihan · Na-update Ago 17, 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York
Nagre-recruitPhase 1/2
Edad 18 pataas · Kababaihan · Na-update Ago 13, 2026 · NCT06040970Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Brooklyn
- Research Site, Stony Brook
- Research Site, The Bronx
- at 1 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Hul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Nagre-recruitPhase 2
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Nagre-recruitObservasyonal na pag-aaral
30 Days · Lahat ng kasarian · Na-update Mar 3, 2025 · NCT06203106Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.